Skip to content
Dose Brief
Menu

WeightCare review

By Updated

WeightCare offers flexible monthly GLP-1 plans and prepaid options, with important differences between starter pricing, renewal and higher doses.

Brief Score72/100Grade CNo. 136 in our directory
Visit WeightCare View the provider’s current plans and terms.

On the record

The FDA issued a warning letter to Weightless Medical LLC dba WeightCare in February 2026. Read the letter in the FDA's warning letter database for the agency's findings.

Semaglutide

$399/mo monthly plan

Compounded semaglutide; three-month starter $747 upfront. Confirm later-dose pricing and state eligibility.

Full price details

$399/month compounded semaglutide plan; $747 upfront for the listed 3-month starter option; confirm continuation dose and price

Tirzepatide

$499/mo monthly plan

Compounded tirzepatide; three-month starter $897 upfront, listed three-month renewal $997 at 7.5 mg. Higher doses differ.

Full price details

$499/month compounded tirzepatide plan; $897 upfront for the listed 3-month starter; renewal and high-dose packages differ

Coverage
Standard GLP-1 FAQ excludes AK, HI, LA and MS; Alabama eligibility conflicts on the semaglutide page. Other programs have different exclusions
Brand-name
Not confirmed

Prices checked against WeightCare's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Monthly plans are $399 for semaglutide and $499 for tirzepatide. The $897 tirzepatide starter package differs from its listed $997 three-month renewal.

WeightCare in depth

Monthly flexibility versus starter pricing

WeightCare lists a $399 monthly semaglutide plan and a $499 monthly tirzepatide plan. It also advertises semaglutide at $747 upfront for a three-month starter package and tirzepatide at $897 for a three-month starter. Those prepaid totals should sit beside the monthly options, rather than being presented as equally flexible monthly payments.

Tirzepatide renewal deserves particular attention. The FAQ lists a $997 three-month renewal for a 7.5 mg weekly program, above the $897 starter charge. Higher-dose packages are $1,350 for three months or $2,150 for six months. Annual-plan tiles show a lower monthly equivalent without a verified full upfront charge, so obtain the payment schedule before comparing them.

Check dose coverage and state access

The program includes clinical review, medication, physician messaging and follow-ups. Dose coverage varies by package: tirzepatide starter materials describe doses through 7.5 mg, while separate higher-dose plans cover continuation. Embody takes a different position, saying its selected plan price does not rise with dose. Semaglutide copy is less consistent, pairing all-dose language with a starter-only tile. Confirm what happens to your bill if your clinician changes the prescription.

Standard GLP-1 FAQ exclusions are Alaska, Hawaii, Louisiana and Mississippi. The semaglutide product page also excludes Alabama in one passage, so access there remains uncertain. Other treatments have different state restrictions. Medication comes from a compounding pharmacy, but the reviewed pages did not identify the pharmacy assigned to each patient; use the pharmacy checklist before ordering.

Canceling does not refund prepaid time

The refund policy allows a full refund before the medical questionnaire is submitted or if the assigned physician finds treatment inappropriate. After submission, refunds are generally unavailable. Canceling stops future charges but does not automatically stop a paid shipment or return money for unused time. The FAQ also advertises notice seven days before renewal.

A discretionary refund after part of a prepaid program ships can be smaller than a simple unused-month calculation. WeightCare subtracts the regular package value of medication already received, using the dose and original purchase date. Read the cancellation guide and compare that policy with your full commitment before choosing a longer plan.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

WeightCare scored on our six Brief Score factors. See the methodology.

Price Stability78/100
Supply Reliability77/100
Transparency72/100
Access Breadth50/100
Clinical Oversight87/100
Track Record64/100

What we like

  • Publishes separate monthly and prepaid medication charges
  • Includes physician messaging and follow-ups
  • Refund policy explains partial-shipment calculations

The caveats

  • Tirzepatide starter and renewal prices differ
  • Annual equivalents do not establish full upfront charges
  • Semaglutide dose coverage and Alabama access need clarification

The brief

Best for: Readers comparing monthly flexibility with prepaid packages who will check the renewal charge and dose coverage. WeightCare offers flexible monthly GLP-1 plans and prepaid options, with important differences between starter pricing, renewal and higher doses.

Ranked #136 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about WeightCare.

Closest here

The providers scoring nearest WeightCare — read each current assessment before choosing care.

Weighing WeightCare against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs WeightCare, and every provider that outranks it is listed on the WeightCare alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect WeightCare's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on WeightCare's site. Not medical advice; see our disclosure.

← Back to all rankings